Macular Edema - 48 Studies Found
Withdrawn |
: Safety Study of ALG- 1001 to Treat Diabetic Macular Edema : Diabetic Macular Edema : 2011-11-28 :
|
Recruiting |
: Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide : CYSTOID MACULAR EDEMA : 2014-11-04 :
|
Completed |
: Glycemic Control and Diabetic Macular Edema : Diabetic Macular Edema : 2011-05-19 : Other: Respond to therapy for diabetic macular edema Correlate HBA1c with visual acuity outcome to thera |
Completed |
: Avastin for Post-Photocoagulation Macular Edema : Macular Edema : 2008-12-03 :
|
Recruiting |
: Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) : Macular Edema : 2016-06-28 : Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) |
Completed |
: Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema : Diabetic Macular Edema : 2014-03-07 |
Withdrawn |
: Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema. : Cystoid Macular Edema : 2007-02-21 :
|
Completed |
: A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) : Diabetic Macular Edema : 2014-03-27 : Drug: Teprotumumab Teprotumumab 20mg/kg administered by intravenous infusion every 3 weeks for 3 infusio |
Completed |
: Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion : Diabetic Macular Edema : 2008-12-26 :
|
Completed |
: Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema : Diabetic Macular Edema : 2011-04-25 : Procedure: Intravitreal injection Intravitreal Injections were done under sterile conditions with topica |